nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—ZEB2—refractive error	0.0731	0.0731	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—RNF111—refractive error	0.0658	0.0658	CbGpPWpGaD
Pimecrolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—RNF111—refractive error	0.0519	0.0519	CbGpPWpGaD
Pimecrolimus—MTOR—Alpha 6 Beta 4 signaling pathway—LAMA2—refractive error	0.0393	0.0393	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—GJD2—refractive error	0.0374	0.0374	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—PML—refractive error	0.0358	0.0358	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—PTPRR—refractive error	0.0325	0.0325	CbGpPWpGaD
Pimecrolimus—MTOR—CDC42 signaling events—RASGRF1—refractive error	0.0284	0.0284	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—AXL—refractive error	0.026	0.026	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—AXL—refractive error	0.0245	0.0245	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1D—refractive error	0.0237	0.0237	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—COL2A1—refractive error	0.0216	0.0216	CbGpPWpGaD
Pimecrolimus—MTOR—mTOR signaling pathway—PML—refractive error	0.0167	0.0167	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—RASGRF1—refractive error	0.0159	0.0159	CbGpPWpGaD
Pimecrolimus—MTOR—CDC42 signaling events—PAX6—refractive error	0.0148	0.0148	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.0127	0.0127	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—BMP2—refractive error	0.011	0.011	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.0104	0.0104	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—COL9A1—refractive error	0.0103	0.0103	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.0102	0.0102	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—PML—refractive error	0.00859	0.00859	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—BMP2—refractive error	0.00851	0.00851	CbGpPWpGaD
Pimecrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PDGFRA—refractive error	0.00802	0.00802	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GREM2—refractive error	0.00787	0.00787	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00753	0.00753	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—DSE—refractive error	0.00724	0.00724	CbGpPWpGaD
Pimecrolimus—MTOR—PI-3K cascade—PDGFRA—refractive error	0.00723	0.00723	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—PDGFRA—refractive error	0.00705	0.00705	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—PDGFRA—refractive error	0.007	0.007	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PDGFRA—refractive error	0.00684	0.00684	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RDH5—refractive error	0.00681	0.00681	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CHN1—refractive error	0.00669	0.00669	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PCCA—refractive error	0.00646	0.00646	CbGpPWpGaD
Pimecrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00645	0.00645	CbGpPWpGaD
Pimecrolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00637	0.00637	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—OR2M7—refractive error	0.00597	0.00597	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IPO5—refractive error	0.0059	0.0059	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—WNT10A—refractive error	0.00549	0.00549	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—PDGFRA—refractive error	0.0054	0.0054	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00523	0.00523	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFITM2—refractive error	0.00519	0.00519	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—RNF111—refractive error	0.00518	0.00518	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00517	0.00517	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RNF111—refractive error	0.00516	0.00516	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—PDGFRA—refractive error	0.00509	0.00509	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VIPR2—refractive error	0.00507	0.00507	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—PDGFRA—refractive error	0.00486	0.00486	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—PDGFRA—refractive error	0.00483	0.00483	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—PDGFRA—refractive error	0.00481	0.00481	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—PDGFRA—refractive error	0.00479	0.00479	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RDH5—refractive error	0.00477	0.00477	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—refractive error	0.00472	0.00472	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AXL—refractive error	0.00452	0.00452	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—PDGFRA—refractive error	0.0045	0.0045	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.0045	0.0045	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—PDGFRA—refractive error	0.0045	0.0045	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—LUM—refractive error	0.00447	0.00447	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—PDGFRA—refractive error	0.00446	0.00446	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GREM2—refractive error	0.00443	0.00443	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00442	0.00442	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CTSC—refractive error	0.00441	0.00441	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—PDGFRA—refractive error	0.0044	0.0044	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—PDGFRA—refractive error	0.00417	0.00417	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VANGL2—refractive error	0.00413	0.00413	CbGpPWpGaD
Pimecrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.00412	0.00412	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—DSE—refractive error	0.00407	0.00407	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00399	0.00399	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.00387	0.00387	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—WNT10A—refractive error	0.00384	0.00384	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RDH5—refractive error	0.00383	0.00383	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CHN1—refractive error	0.00376	0.00376	CbGpPWpGaD
Pimecrolimus—MTOR—PI-3K cascade—PTEN—refractive error	0.00371	0.00371	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PCCA—refractive error	0.00363	0.00363	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—PTEN—refractive error	0.00362	0.00362	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—RPS27—refractive error	0.00362	0.00362	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CER1—refractive error	0.00361	0.00361	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RNF111—refractive error	0.00361	0.00361	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TJP2—refractive error	0.00361	0.00361	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—PTEN—refractive error	0.00359	0.00359	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00351	0.00351	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.00351	0.00351	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—OR2M7—refractive error	0.00335	0.00335	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IPO5—refractive error	0.00332	0.00332	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RNF111—refractive error	0.00314	0.00314	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—WNT10A—refractive error	0.00309	0.00309	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—PDGFRA—refractive error	0.00307	0.00307	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RNF111—refractive error	0.0029	0.0029	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VIPR2—refractive error	0.00285	0.00285	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.00278	0.00278	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—PTEN—refractive error	0.00277	0.00277	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.00274	0.00274	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—COL9A1—refractive error	0.00274	0.00274	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RDH5—refractive error	0.00268	0.00268	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTSC—refractive error	0.00267	0.00267	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—PTEN—refractive error	0.00265	0.00265	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—refractive error	0.00263	0.00263	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—PTEN—refractive error	0.00261	0.00261	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AXL—refractive error	0.00254	0.00254	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—LUM—refractive error	0.00252	0.00252	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin Signaling—PTEN—refractive error	0.00251	0.00251	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—PTEN—refractive error	0.00249	0.00249	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—PTEN—refractive error	0.00248	0.00248	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00248	0.00248	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—PTEN—refractive error	0.00247	0.00247	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—PTEN—refractive error	0.00246	0.00246	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.00242	0.00242	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VANGL2—refractive error	0.00233	0.00233	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—PTEN—refractive error	0.00231	0.00231	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—PTEN—refractive error	0.00231	0.00231	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00231	0.00231	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—PTEN—refractive error	0.00229	0.00229	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—PTEN—refractive error	0.00227	0.00227	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—PTEN—refractive error	0.00226	0.00226	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—WNT10A—refractive error	0.00216	0.00216	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—PTEN—refractive error	0.00214	0.00214	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00205	0.00205	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—RPS27—refractive error	0.00204	0.00204	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RNF111—refractive error	0.00203	0.00203	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CER1—refractive error	0.00203	0.00203	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TJP2—refractive error	0.00203	0.00203	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—BMP2—refractive error	0.00188	0.00188	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PDGFRA—refractive error	0.00175	0.00175	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PML—refractive error	0.00171	0.00171	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—PDGFRA—refractive error	0.00168	0.00168	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PDGFRA—refractive error	0.00167	0.00167	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—PTEN—refractive error	0.00158	0.00158	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—COL9A1—refractive error	0.00154	0.00154	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—EBP—refractive error	0.00119	0.00119	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PDGFRA—refractive error	0.00117	0.00117	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—BMP2—refractive error	0.00106	0.00106	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PDGFRA—refractive error	0.00102	0.00102	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PDGFRA—refractive error	0.000941	0.000941	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DSE—refractive error	0.000905	0.000905	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PTEN—refractive error	0.000898	0.000898	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—PTEN—refractive error	0.000863	0.000863	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTEN—refractive error	0.000859	0.000859	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLA2G16—refractive error	0.000807	0.000807	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PCCA—refractive error	0.000807	0.000807	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PDGFRA—refractive error	0.000659	0.000659	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTEN—refractive error	0.000601	0.000601	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LUM—refractive error	0.000559	0.000559	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CACNA1D—refractive error	0.000538	0.000538	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTEN—refractive error	0.000523	0.000523	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTEN—refractive error	0.000483	0.000483	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP26A1—refractive error	0.000475	0.000475	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTEN—refractive error	0.000338	0.000338	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTEN—refractive error	0.000107	0.000107	CbGpPWpGaD
